November 7, 2018 08:11 AM EST
Bioregnum
Opinion

Bound to the hip with Trump, ex-Cel­gene chief Bob Hug­in gets whipped in New Jer­sey Sen­ate race

This wasn’t Bob Hug­in’s year to start a new ca­reer in pol­i­tics.

The ex-Cel­gene ex­ec, wide­ly laud­ed in the in­vest­ment com­mu­ni­ty for the com­pa­ny’s fast …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE
TRENDING NOW

Trump asks 'very tough hom­bre' Dr. Oz to lead MFN talks

US warns drug­mak­ers against mis­rep­re­sent­ing cost of im­port­ed prod­ucts

End­points 100 biotech sur­vey: Wel­come to the sum­mer of biotech’s dis­con­tent

About 5% of CBER and CDER left af­ter FDA staff cuts, analy­sis finds

Big leas­es, big­ger re­grets: Biotech slump turns swanky of­fices from as­set in­to li­a­bil­i­ty

sponsored

Does your sup­ply chain hold up un­der pres­sure for high-risk tem­per­a­ture-crit­i­cal ship­ments?

A service from the Financial Times